Viking Therapeutics Reaches Analyst Target Price
February 19, 2024 at 10:57 AM EST
In recent trading, shares of Viking Therapeutics Inc (VKTX) have crossed above the average analyst 12-month target price of $36.00, changing hands for $36.20/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..